Member - phagos
Phagos develops a sustainable alternative to antibiotics, driven by advanced microbiology and AI.
About
Antibiotic resistance is a critical global threat, linked to 5 million deaths annually and costing $100 trillion by 2050. Phagos combats this crisis by building high-efficiency phage-based antibacterials 100x faster and cheaper than antibiotics. Our ML/GenAI platform predicts optimal phage combinations with 95% accuracy, developing resistance-proof cocktails in under 2 months using proprietary workflows – a speed competitors can't match.
Headquarters 92150 Suresnes, France
SDG’s of application
The Sustainable Development Goals are a call to action to end poverty, protect the planet and ensure peace and prosperity everywhere.
SDG 6
Clean water and sanitation
SDG 7
Affordable and clean energy
SDG 9
Industry, innovation and infrastructure
SDG 11
Sustainable cities and communities
SDG 12
Responsible consumption and production
The information set out above, is solely for the purposes of information and the Solar Impulse Foundation does not provide any guarantee as to its authenticity, completeness or accuracy. To validate the Membership to the World Alliance for Efficient Solutions, the Solar Impulse Foundation only verifies that each entity is registered and has signed our principles and values stated in the following World Alliance for Efficient Solutions charter. For those Members who are also solution providers, this information does not constitute investment advice or a recommendation to buy into, transact or to enter into any agreement with any of the parties or persons mentioned above. Potential investors or interested parties are solely responsible for their investment or business decisions and for performing any due diligence required by the circumstances.
